“We believe in constantly challenging ourselves to create the most advanced, effective medical devices & solutions for the esthetic market.
We believe in thinking differently.”
Geneo+™ Technology is developed by Pollogen Ltd.
Pollogen Ltd. develops, manufactures and markets professional medical aesthetic devices. Pollogen’s products offer a non-invasive, minimal invasive and non-surgical solution for acne scars, cellulite reduction, circumference reduction, facial contouring, fractional skin resurfacing, muscle lifting, skin rejuvenation, skin tightening and wrinkle reduction.
In everything we do, we take a customer-centric approach by making our products user-friendly, safe and convenient. At Pollogen there is no such word as “done”; we continually perfect our solutions to provide treatments that are pleasant and effective. We believe in finding ways to develop technologies that work with the body’s natural mechanisms so beautiful results are generated from within.
Pollogen is the developer and manufacturer of five revolutionary technologies under the industry premier brand names OxyGeneo™, Hybrid Energy™, and MyPollogen™ Face & Body Treatments (powered by TriPollar®, TriLipo® and TriFractional™).
We offer a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a wide range of aesthetic applications. Pollogen provides solutions for professionals in over 60 countries, addressing the specific needs and dynamic changes unique to the ever-evolving aesthetic industry.
Pollogen is committed to the safety of its customers and to product excellence. Pollogen products are sold in over 60 countries and adhere to strict international and national regulatory and quality assurance standards.
- ISO 13485:2003 certification
- ISO 9001:2008 certification
- CE Mark
Contact Pollogen to receive information about FDA, CE Mark and ISO documentation.